Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

FDA approves IND application for clinical study of RK-01

June 11, 2018

Updated interim data from phase I/II study of lumasiran for primary hyperoxaluria type 1

June 8, 2018

Minesapride shows clinical efficacy in irritable bowel syndrome with constipation

June 8, 2018

Luye Pharma and Elpis expand collaboration in immuno-oncology

June 8, 2018

First celiac disease model with a humanized immune system reported

June 8, 2018

MyoKardia opens phase III study of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy

June 8, 2018

TET2 disruption improves antitumor activity of CAR T-cell therapy in a CLL patient

June 8, 2018

Roche patents anti-pY796-DDR1 antibodies

June 8, 2018

Mitochondrial aging in directly induced neurons may help understand neurodegenerative diseases

June 8, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...